Get Live Data

Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share Regulatory News
  5. GSK publishes provisional dividend dates

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1,957.50    33.00 (1.71%)
Bid:
1,961.00
Ask:
1,961.50
Spread: 0.50 (0.025%)
Market Cap: £78.45b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

GSK publishes provisional dividend dates

10 Nov 2025 15:00

RNS Number : 7689G
GSK PLC
10 November 2025
 

GSK plc

 

GSK publishes provisional dividend dates

 

 

GSK announces the following dividend dates for 2026:

 

 

These dates are indicative and may be subject to change.

 

 

Results

Announcement date

Ordinary Shares Ex-dividend date

American Depositary Shares Ex-dividend date

Record date

Last date for DRIP elections

Payable

Q1 2026

Wednesday 29 April 2026

 

Thursday 14 May 2026

 

Friday 15 May 2026

Friday 15 May 2026

Thursday 18 June 2026

Thursday 9 July 2026

Q2 2026

Wednesday 29 July 2026

Thursday 13 August 2026

 

Friday 14 August 2026

 

Friday 14 August 2026

Thursday 17 September 2026

Thursday 8 October 2026

Q3 2026

 

Wednesday 28 October 2026

 

Thursday 12 November 2026

Friday 13 November 2026

Friday 13 November 2026

Monday 14 December 2026

Thursday 7 January 2027

Q4 2026

 

Wednesday 3 February 2027

 

Thursday 18 February 2027

Friday 19 February 2027

Friday 19 February 2027

Tuesday 16 March 2027

Thursday 8 April 2027

 

 

V A Whyte

Company Secretary

 

 

10 November 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVMZMGMMLMGKZM
12345678910
Date   Source Headline
23rd Jun 20263:30 pmRNSDirector/PDMR Shareholding
22nd Jun 20263:00 pmRNSTransaction in Own Shares
17th Jun 20264:06 pmRNScUTI oral antibiotic Tebipenem approved by US FDA
15th Jun 20263:00 pmRNSTransaction in Own Shares
12th Jun 20267:00 amRNSMomelotinib orphan drug designations for VEXAS
11th Jun 20263:30 pmRNSDirector/PDMR Shareholding
10th Jun 20263:30 pmRNSDirector/PDMR Shareholding
9th Jun 20265:51 pmRNSDr Hal Barron – New Directorship
9th Jun 20267:00 amRNSGSK enters agreement to acquire Nuvalent, Inc.
8th Jun 20263:00 pmRNSTransaction in Own Shares
1st Jun 20263:00 pmRNSTotal Voting Rights
1st Jun 20263:00 pmRNSTransaction in Own Shares
28th May 20269:30 amRNSPositive Phase 3 data for bepirovirsen
27th May 20263:30 pmRNSDirector/PDMR Shareholding
26th May 20263:00 pmRNSAdmission to Trading
26th May 20263:00 pmRNSTransaction in Own Shares
22nd May 202610:30 amRNSQ2 2026 Results Date Confirmed - 28 July 2026
20th May 20263:30 pmRNSDirector/PDMR Shareholding
19th May 20263:30 pmRNSDirector/PDMR Shareholding
18th May 20263:00 pmRNSTransaction in Own Shares
18th May 20267:00 amRNSJapan MHLW approves Arexvy for adults 18-49 AIR
14th May 20263:30 pmRNSDirector/PDMR Shareholding
11th May 20263:30 pmRNSDirector/PDMR Shareholding
11th May 20267:05 amRNSCollaboration with CTTQ for bepirovirsen
11th May 20267:00 amRNSGSK - final tranche of share buyback programme
6th May 20266:22 pmRNSResult of AGM
5th May 20263:30 pmRNSDirector/PDMR Shareholding
1st May 20263:00 pmRNSHolding(s) in Company
1st May 20263:00 pmRNSTotal Voting Rights
29th Apr 20263:30 pmRNSDirector/PDMR Shareholding
29th Apr 20267:00 amRNS1st Quarter Results
28th Apr 20263:30 pmRNSDirector/PDMR Shareholding
28th Apr 20267:00 amRNSBepirovirsen priority review US filing acceptance
27th Apr 202612:00 pmRNSEfimosfermin granted US/EU regulatory designations
27th Apr 20267:00 amRNSTESARO update on AnaptysBio Inc. litigation
24th Apr 20263:30 pmRNSDirector/PDMR Shareholding
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20263:30 pmRNSDirector/PDMR Shareholding
20th Apr 20267:00 amRNSBlenrep approved in China for 2L+ multiple myeloma
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20263:30 pmRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:12 amRNSGSK completes acquisition of 35Pharma Inc.
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20263:30 pmRNSDirector/PDMR Shareholding
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20263:30 pmRNSDirector/PDMR Shareholding
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
DD25
Investec Bnk 25
LSE
0.00%
E127
Amundi Emmk Gbp
LSE
-4.75%
GVP
GVP.L
LSE
0.00%
13NK
13NK.L
LSE
0.00%
ITM
Itm Power
LSE
-3.66%
Trending
QHE
Quantum Helium
LSE
-1.67%
PREM
Premier African Minerals
LSE
7.50%
EZJ
easyJet
LSE
2.24%
AVCT
Avacta Group
LSE
0.28%
KEFI
Kefi Gold & Copper
LSE
-0.57%